Showing results (31-40 of 115) with videos related to
Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
An update on therapeutic opportunities offered by cancer glycolytic metabolismCarlotta Granchi, Daniele Fancelli, Filippo MinutoloSeminars in Cancer Biology|August 25, 2019
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategiesBtissame El Hassouni, Carlotta Granchi, Andrea Vallés-Martí, et al.Journal of Medicinal Chemistry|February 5, 2019
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) InhibitorCarlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.Future Medicinal Chemistry|November 2, 2013
Small-molecule inhibitors of human LDH5Carlotta Granchi, Ilaria Paterni, Reshma Rani, et al.Molecules (Basel, Switzerland)|April 29, 2020
Application of MM-PBSA Methods in Virtual ScreeningGiulio Poli, Carlotta Granchi, Flavio Rizzolio, et al.Steroids|June 28, 2014
Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potentialIlaria Paterni, Carlotta Granchi, John A Katzenellenbogen, et al.Molecular Metabolism|March 25, 2026
Dynamic Evaluation Of The Glycolytic Determinants LDH-A And GLUT-1 Enhances Prognostic Significance And Their Inhibition Affect The Growth Of Mesothelioma SpheroidsMarika A Franczak, Federica Borea, Valentina Donati, et al.Expert Opinion on Therapeutic Patents|May 30, 2013
Estrogen receptor ligands: a patent review updateIlaria Paterni, Simone Bertini, Carlotta Granchi, et al.Expert Opinion on Therapeutic Patents|October 21, 2017
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)Carlotta Granchi, Isabella Caligiuri, Filippo Minutolo, et al.Molecules (Basel, Switzerland)|December 14, 2017
Three-Dimensional Analysis of the Interactions between hLDH5 and Its InhibitorsGiulio Poli, Carlotta Granchi, Mohamed Aissaoui, et al.Pageof 12